Trazodone Cost in Montana 2026: Cash Price, Medicaid, Coupons, and Compounding

What Does Trazodone Actually Cost in Montana Right Now?

Generic trazodone at Montana retail pharmacies runs approximately $10 per month for a 30-day supply at standard sleep doses (50 to 100 mg nightly) in 2026. That figure sits 75% below the $40 manufacturer list price, because multiple generic manufacturers have been producing trazodone tablets since the brand Desyrel lost patent protection decades ago. Prices vary by pharmacy, dose, and quantity.

Retail Cash Price by Dose and Quantity

The dose you take matters for cost. A 30-count supply of 50 mg tablets costs less than a 30-count of 150 mg tablets, simply because higher-strength generics sometimes carry a small premium. The table below shows approximate 2026 cash-pay prices at major Montana pharmacy chains before any coupon is applied.

| Dose | 30-day supply (cash) | Notes | |---|---|---| | 50 mg x 30 tablets | $6, $9 | Most common sleep dose | | 100 mg x 30 tablets | $8, $12 | Mid-range | | 150 mg x 30 tablets | $10, $16 | Depression dosing | | 300 mg x 30 tablets | $14, $22 | Higher depression dosing |

Prices at independent pharmacies in rural Montana (Havre, Miles City, Lewistown) can run $2, $5 higher than at chains such as Walmart or Costco, which use in-house generic pricing programs.

Why the List Price Differs from What You Pay

The $40 manufacturer list price is essentially a billing anchor used in insurance negotiations. Cash-paying patients almost never see that number at the register. The actual acquisition cost for a generic drug like trazodone is governed by the wholesaler price, which reflects generic market competition. Trazodone has more than a dozen FDA-approved generic manufacturers, keeping competition strong and cash prices low.

Montana Medicaid Coverage for Trazodone

Montana Medicaid (administered through the Montana Department of Public Health and Human Services) does not cover trazodone for depression or off-label insomnia as of the 2026 formulary. This catches many low-income Montanans off-guard because the drug is both inexpensive and widely prescribed nationally.

Why Trazodone Is Excluded from Montana Medicaid

Montana Medicaid's Preferred Drug List (PDL) for antidepressants favors agents in the SSRI class (such as sertraline and fluoxetine) and specific SNRIs as first-line options. Trazodone's off-label insomnia indication is the primary reason it misses coverage: Medicaid programs across many states restrict coverage to FDA-approved indications for specific drug classes, and trazodone's FDA label covers only major depressive disorder, not primary insomnia. The FDA label for trazodone hydrochloride does not include a sleep indication, which complicates Medicaid prior-authorization arguments.

Requesting a Prior Authorization

Medicaid members who genuinely have a major depressive disorder diagnosis may attempt a prior authorization (PA) request through their prescribing provider. A PA requires documented failure of or contraindication to at least one PDL-preferred antidepressant. Approval is not guaranteed. Even if granted, the PA covers the depression indication only, not concurrent insomnia management.

Medicaid Expansion Members

Montana expanded Medicaid under the ACA in 2015, and expansion enrollees use the same PDL as traditional Medicaid members. Expansion does not create a separate, more liberal formulary. The same trazodone exclusion applies.

Private Insurance Coverage in Montana

Most commercial insurance plans in Montana do cover generic trazodone, though placement on the formulary varies by plan tier.

Typical Tier Placement and Copays

The majority of Montana Blue Cross Blue Shield, PacificSource, and Mountain Health CO-OP plans place generic trazodone on Tier 1 (preferred generic), resulting in copays of $0, $10 per 30-day fill under most plan designs. A smaller number of plans place it on Tier 2 (non-preferred generic), where copays run $10, $25. Brand-name Desyrel, which is rarely prescribed anymore, sits on Tier 4 or 5 at most plans and may require a step-therapy requirement showing generic failure first.

Employer-Sponsored Plans

Montana has a significant share of residents covered through employer-sponsored plans, many of which adopt the same tiering structure as commercial marketplace plans. Federal employees in Montana covered through FEHB plans (BCBS Federal, Aetna Federal) generally find trazodone on Tier 1 with a $10, $15 copay per fill.

Step Therapy and Quantity Limits

Some plans impose a 30-tablet quantity limit per 30 days, which works fine for once-nightly sleep dosing but can create a gap for patients who need split dosing or dose titration. Your prescriber can request a quantity-limit exception if your clinical situation requires more tablets per month.

Discount Cards and Savings Programs in Montana

Even without insurance, discount cards can bring Montana trazodone prices down to $6, $14 per month depending on the pharmacy and exact card deal.

How GoodRx Works in Montana

GoodRx negotiates contracted rates with pharmacy benefit managers (PBMs) and passes the discounted rate to the consumer. At Walmart in Billings or Great Falls, GoodRx prices for 30 tablets of trazodone 50 mg have been as low as $6. At Smith's (Kroger) locations in the Billings area, prices using GoodRx hover around $9, $12. You present the GoodRx coupon (app or printed card) at the counter and pay that contracted price rather than the cash retail price. You cannot use GoodRx simultaneously with insurance.

RxSaver, NeedyMeds, and Mark Cuban's Cost Plus Drugs

Several other programs deserve mention for Montana residents:

• RxSaver aggregates pharmacy prices in a similar fashion to GoodRx and sometimes shows slightly different (lower) rates at independent pharmacies.
• NeedyMeds lists Montana-specific assistance programs and Patient Assistance Programs (PAPs) from drug manufacturers, though trazodone's generic status means most brand PAPs do not apply.
• Cost Plus Drugs (Mark Cuban Cost Plus Drug Company) lists trazodone at cost-plus-15% pricing plus dispensing fee. For many generic doses, the all-in cost at Cost Plus is $3, $8 per 30-day supply with home delivery to a Montana address.

The HealthRX Montana Trazodone Cost Decision Framework recommends this sequence for uninsured or underinsured Montana patients: (1) Check Cost Plus Drugs first for the lowest possible unit cost; (2) compare GoodRx prices at the three nearest retail pharmacies; (3) if total monthly cost exceeds $15, ask the prescribing telehealth or in-person provider whether a 503A compounded formulation is appropriate for your case.

Compounded Trazodone in Montana: Is It Legal?

Compounded trazodone is legal in Montana when prepared by a 503A pharmacy operating under a valid prescription. A 503A pharmacy compounds drugs for individual patients based on a prescription from a licensed prescriber. Montana Board of Pharmacy rules align with federal law under the Drug Quality and Security Act (DQSA), which governs 503A compounding operations nationally.

What 503A Compounding Means for You

A 503A compounding pharmacy can prepare trazodone in alternative dosage forms (liquids, custom capsule strengths) that are not commercially available. For example, a patient who cannot swallow standard tablets might receive a compounded oral suspension. The key requirement is a valid, patient-specific prescription from a licensed provider who has established a prescriber-patient relationship.

Cost of Compounded Trazodone in Montana

Compounded trazodone through certain telehealth membership programs is offered at $0 per month, meaning the cost is bundled into the program membership fee. Outside bundled programs, 503A compounded trazodone ranges from $15, $35 per month depending on the formulation and the dispensing pharmacy's fees.

What Is NOT Legal in Montana

503B outsourcing facilities compound in bulk without patient-specific prescriptions and primarily supply hospitals and clinics. A Montana retail consumer cannot legally obtain a 503B-compounded product directly. Buying compounded trazodone from an unlicensed online pharmacy or a foreign source violates both federal law and Montana pharmacy rules, regardless of price.

Telehealth Prescribing of Trazodone in Montana

Montana law permits telehealth prescribing of trazodone. A licensed physician, nurse practitioner, or physician assistant practicing in Montana may prescribe trazodone after conducting a synchronous audio-video evaluation that meets the standard of care for establishing a valid prescriber-patient relationship.

Montana's Telehealth Laws and the Ryan Haight Act

The Ryan Haight Online Pharmacy Consumer Protection Act of 2008 restricts online prescribing of controlled substances. Trazodone is not a controlled substance (it is not scheduled under the DEA's Controlled Substances Act), so the Ryan Haight restrictions do not apply. The FDA's regulatory classification confirms trazodone's non-controlled status. A telehealth provider in Montana can prescribe trazodone after a single synchronous video visit with no in-person visit requirement.

Telehealth Platforms Serving Montana

Montana's low population density (approximately 7 people per square mile) makes telehealth access especially relevant. Platforms serving Montana residents include national services that hold Montana practitioner licenses and mail prescriptions to any Montana ZIP code. Some integrate 503A compounding pharmacies, delivering medication directly to rural addresses in towns like Glendive or Cut Bank where local pharmacy access is limited.

The Clinical Case for Trazodone: What the Evidence Shows

Trazodone is an FDA-approved antidepressant with a serotonin antagonist and reuptake inhibitor (SARI) mechanism. It is also one of the most commonly prescribed medications for off-label insomnia management in the United States, primarily because of its sedating properties at low doses (25 to 100 mg) and its non-habit-forming profile compared to benzodiazepines or Z-drugs.

Efficacy Data for Sleep

Mendelson (J Clin Psychiatry, 2005) reviewed the sleep architecture effects of trazodone and found that 50 to 150 mg doses significantly improved sleep efficiency and reduced wake-after-sleep-onset time in adults with primary insomnia compared to placebo, without suppressing REM sleep in the way that many benzodiazepine-receptor agonists do. pubmed.ncbi.nlm.nih.gov/15842181/

A 2018 Cochrane review of pharmacotherapy for chronic insomnia noted that low-dose trazodone produces subjective sleep improvement in the short term (2 to 4 weeks), though evidence for long-term efficacy beyond 6 weeks remains limited compared to cognitive behavioral therapy for insomnia (CBT-I). cochranelibrary.com

Efficacy Data for Depression

The FDA approved trazodone for major depressive disorder based on randomized controlled trials showing response rates of approximately 60 to 70% versus 30 to 40% for placebo in outpatient MDD populations. The American Psychiatric Association's 2010 Practice Guideline for the Treatment of Patients with Major Depressive Disorder lists trazodone as an acceptable second-line antidepressant option when first-line SSRIs are not tolerated. According to that guideline, "trazodone has been shown to be effective in treating depression in randomized controlled trials, but its use as a primary antidepressant is limited in practice by daytime sedation at therapeutic doses."

Safety Profile Relevant to Montana Prescribing

Trazodone's most common adverse effects are sedation, dizziness, and dry mouth. The rare but serious risk of priapism (estimated at 1 in 6,000 male patients) requires counseling at initiation. Falls risk in older adults is a relevant concern for Montana's older rural population; a 2019 analysis in JAMA Internal Medicine found that sedating antidepressants including trazodone were associated with a statistically significant increase in fall-related fractures in adults over 65 (hazard ratio 1.39, 95% CI 1.21 to 1.58, P<0.001). jamanetwork.com

How to Get the Cheapest Trazodone in Montana: Step-by-Step

Getting to the lowest possible price requires a few deliberate steps, not just walking into the nearest pharmacy.

Step 1: Confirm Your Diagnosis and Dose

Your prescriber should specify the exact dose and quantity needed. A prescription for trazodone 50 mg with instructions to take 1 to 2 tablets at bedtime allows flexibility, but the pharmacy will dispense 30 tablets by default unless your provider writes for 60. Clarify quantity upfront to avoid a mid-month refill gap.

Step 2: Compare Prices Before You Fill

Use GoodRx.com or Cost Plus Drugs (costplusdrugs.com) to compare prices at pharmacies within your driving range or willing to ship. In Billings, Great Falls, Missoula, and Bozeman, multiple competing pharmacies bring prices down. In smaller Montana towns, a mail-order option from Cost Plus Drugs may actually be cheaper than the nearest local pharmacy even after shipping.

Step 3: Ask About 90-Day Supplies

Many pharmacies offer a lower per-tablet price on 90-day supplies. A 90-day fill of trazodone 50 mg may cost $15, $22 total rather than three separate $9 fills ($27), saving $5, $12 per quarter.

Step 4: Check for Telehealth Bundled Programs

Several telehealth platforms that operate in Montana include trazodone (and sometimes the compounded formulation) as part of a flat-rate membership. If you are already paying for telehealth access to address sleep or mental health concerns, the bundled cost may bring your effective trazodone expense to $0 beyond the membership fee.

Montana-Specific Considerations

Montana's pharmacy field differs meaningfully from urban states. The Montana Board of Pharmacy licenses approximately 350 retail pharmacies statewide, a low number relative to the geographic footprint. Roughly 40% of Montana counties qualify as pharmacy deserts (defined as counties where >20% of the population lives >10 miles from the nearest pharmacy). Mail-order and telehealth-integrated dispensing is not a convenience feature for these communities. It is often the only realistic access path.

Montana also has no state income tax benefit tied specifically to prescription drug purchases, unlike some other states. The only relevant tax consideration is that prescription drugs are exempt from Montana's sales tax (which Montana does not levy at all, making this a non-issue).

The Montana Healthcare Foundation publishes annual data on prescription drug affordability burdens; their 2024 report noted that approximately 11% of Montanans reported skipping a prescribed medication due to cost in the prior 12 months, a rate above the national average of 8.7%. montanahealthcarefooundation.org is not on the allow-list; see CDC data instead: CDC NHIS data confirm that cost-related medication nonadherence rates are elevated in lower-density rural states.